Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2024-12-12 00:00:00 ET · period of report 2024-12-12 · accession 0001437749-24-037353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-12 | 2024-12-12 | PVLA | GERAGHTY JAMES A | Dir | D - Sale to Iss | $0.01 | -1 | 0 | -100% | -$0.01 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series F Preferred Stock, par value $0.001 per share | 2024-12-12 | D | D | 1 | $0.01 | 0 | D | — | — | (F1) This Form 4 relates to the redemption of the Series F Preferred Stock, par value $0.001, that was issued to James A. Geraghty on August 7, 2024. The Series F Preferred Stock was redeemed by Pieris Pharmaceuticals, Inc. for $0.01 automatically and effective immediately after the effectiveness of its Authorized Share Increase, as set forth in the Certificate of Designation of Series F Preferred Stock. |